We are monitoring the impact of COVID-19 on Active Implantable Medical Devices Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 4847
Share on
Share on

Global Active Implantable Medical Devices Market Analysis - By Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing Devices), By Region - Industry Size, Share, Growth, Trends, Forecast | 2019 - 2024

Pulished: August, 2019
ID: 4847
Pages: 185

Global Active Implantable Medical Devices Market Size (2019-2024)

The size of the global active implantable medical devices market is growing at a 7.76% CAGR from 2019 to 2024. The market was worth USD 23.1 Billion in 2019 and will reach USD 33.6 billion by 2024. Factors such as the growing incidence of cardiovascular diseases and rising support to technological developments are primarily driving the market growth.

Growing ageing population is another crucial aspect of driving demand to the active implantable medical devices.

The growing elderly population is one of the critical elements of the global active implantable medical devices market growth. The people over the age of 65 is supposed to increase from 524 million in 2010 to about 1.5 billion in 2050. By 2050, the global age-group over 80 will have 379 million, expected to be 5.5 times the 65 million in 2000. Age is associated with a gradual decline in functional reserve in multiple organ systems, including the heart, brain, and ears. It is not surprising that elderly patients use imbalanced medical resources, as about 92% of the elderly have at least one chronic illness, and 77% of the elderly have at least two chronic diseases.

Industry Growth Drivers

  • The emergence of innovative implantable products with enhanced performance and effortless operative procedures is to drive market growth.
  • Favourable government policies are likely to offer several opportunities to the new and well-established manufacturers in the market. 
  • The rising prevalence of cardiovascular diseases and increasing demand for active implantable devices, especially in developing countries, is another promising factor helping the market to reach new heights in growth.
  • An increasing number of activities in medical research to develop advanced and ergonomically enhanced technologies owing to an expanding number in a variety of diseases are offering lucrative growth opportunities and pushing the limits of the global active implantable medical devices market across the world.

Major Challenges

The Global Active Implantable Medical Devices Market in which the issues related to the use of such devices, such as those related to device failure and network security, may hinder market growth soon. The high cost and adverse compensation policies of implantable medical devices are vital challenges and limit the adoption of active implantable medical device solutions in the global business.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 – 2024

Segments Covered

By Product and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global active implantable medical devices market has been segmented and sub-segmented based on the product and region.

Active Implantable Medical Devices Market– By Product

  • Implantable Cardioverter Defibrillators
    • Transvenous Implantable Cardioverter Defibrillators
      • Biventricular Implantable Cardioverter Defibrillators (ICDs)/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)
      • Dual-Chamber Implantable Cardioverter Defibrillators
      • Single-Chamber Implantable Cardioverter Defibrillators
    • Subcutaneous Implantable Cardioverter Defibrillator
  • Implantable Cardiac Pacemakers
  • Ventricular Assist Devices
  • Implantable Heart Monitors/Insertable Loop Recorders
  • Neurostimulators
    • Spinal Cord Stimulators
    • Deep Brain Stimulators
    • Sacral Nerve Stimulators
    • Vagus Nerve Stimulators
    • Gastric Electrical Stimulators
  • Implantable Hearing Devices
    • Active Hearing Implants
    • Passive Hearing Implants

Based on the product, the Cardioverter defibrillators segment held the largest share in 2019. It is due to the increase in the prevalence of cardiovascular diseases and high compliance for technologically advanced products.

Another segment which is playing a pivotal role in the growth in the global active implantable medical devices market is transvenous implantable cardioverter defibrillators. Over the sub-segments of this type, the single-chamber implantable cardioverter defibrillators are dominating followed by subcutaneous implantable cardioverter defibrillators.

The neurostimulators market to witness the highest growth rate during the forecast period. The demand for neurostimulators, especially deep brain stimulators, is growing significantly across the globe. An increase in the prevalence of chronic pain, such as neuropathic pain, pain due to diabetes, arthritis, anxiety and suffering from an injury has increased the demand for neurostimulators significantly.

Regional Insights

North America held the largest share in the regional segment of the global active implantable medical devices market. The United States to showcase promising growth in the coming years. Rising healthcare spending and high geriatric population and technological advancements in this region are driving the growth scope to the market.

The European market is next to North America is leading the majority of the shares in the market. However, the market in the Asia-Pacific region to grow at the highest CAGR.

Key market participants in the Global Active Implantable Medical Devices Market profiled in this report are:

  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co. KG
  • LivaNova
  • Cochlear Limited
  • MED-EL
  • Sonova Holding AG
  • William Demant Holding A/S
  • Nurotron Biotechnology Co. Ltd.

Major happenings in the global active implantable medical devices in the recent past:

In May 2019, Medtronic plc developed the Attain Stability Quad MRI SureScan for active fixation of left heart lead which has been paired with pacemakers and defibrillators that are associated with Medtronic’s quadripolar cardiac resynchronization therapy. The device is to attain stability and precision in lead placement, and the product has been approved by the FDA (Food and drug administration in the U.S).

In Aug 2019, Boston scientific corporation completed the acquisition of BTG Plc; a company that is offering a variety of products in streams of speciality pharmaceuticals, cardiovascular and cancer treatment procedures. The strategic collaboration will enable the Boston Scientific Corporation to provide advanced technologies and improve the infrastructure to support professionals treating severe diseases across the world.

In Dec 2019, Impulse Dynamics Company developed a device called the Optimizer smart system, which applies to CCM therapy. The FDA has approved the product for treating cardiac dysfunctions in the patients. The company has been funded by crucial investors such as Amzek Health Investors, Minth Holdings ltd, Acom biosciences, and others.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Introduction                           

                                5.1.2 Implantable Cardioverter Defibrillators                      

                                                5.1.2.1 Transvenous Implantable Cardioverter Defibrillators        

                                                                5.1.2.1.1 Biventricular Implantable Cardioverter Defibrillators (ICDs)/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)

                                                                5.1.2.1.2 Dual-Chamber Implantable Cardioverter Defibrillators

                                                                5.1.2.1.3 Single-Chamber Implantable Cardioverter Defibrillators

                                                5.1.2.2 Subcutaneous Implantable Cardioverter Defibrillator       

                                5.1.3 Implantable Cardiac Pacemakers                   

                                5.1.4 Ventricular Assist Devices                 

                                5.1.5 Implantable Heart Monitors/Insertable Loop Recorders                     

                                5.1.6 Neurostimulators                 

                                                5.1.6.1 Spinal Cord Stimulators  

                                                5.1.6.2 Deep Brain Stimulators  

                                                5.1.6.3 Sacral Nerve Stimulators               

                                                5.1.6.4 Vagus Nerve Stimulators               

                                                5.1.6.5 Gastric Electrical Stimulators        

                                5.1.7 Implantable Hearing Devices                           

                                                5.1.7.1 Active Hearing Implants 

                                                5.1.7.2 Passive Hearing Implants              

                                5.1.5  Y-o-Y Growth Analysis, By Product                              

                                5.1.6  Market Attractiveness Analysis, By Product                            

                                5.1.7  Market Share Analysis, By Product                              

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                6.2 North America                                          

                                6.1.1 Introduction                           

                                6.1.2 United States                         

                                6.1.3 Canada                     

                6.3 Europe                                         

                                6.2.1 Introduction                           

                                6.2.2 U.K                             

                                6.2.3 Spain                         

                                6.2.4 Germany                 

                                6.2.5 Italy                            

                                6.2.6 France                       

                6.4 Asia-Pacific                                 

                                6.3.1 Introduction                           

                                6.3.2 China                         

                                6.3.3 India                          

                                6.3.4 Japan                         

                                6.3.5 Australia                   

                                6.3.6 South Korea                           

                6.5 Latin America                                             

                                6.4.1 Introduction                           

                                6.4.2 Brazil                          

                                6.4.3 Argentina                

                                6.4.4 Mexico                     

                                6.4.5 Rest of Latin America                          

                6.6 Middle East & Africa                                               

                                6.5.1 Introduction                           

                                6.5.2 Middle-East                            

                                6.5.3 Africa                         

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Medtronic plc                                            

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Abbott Laboratories                                               

                8.3 Boston Scientific Corporation                                             

                8.4 BIOTRONIK SE & Co. KG                                        

                8.5 LivaNova PLC.                                            

                8.6 Cochlear Limited                                      

                8.7 MED-EL                                        

                8.8 Sonova Holding AG                                 

                8.9 William Demant Holding A/S                                               

                8.10 Nurotron Biotechnology Co. Ltd.                                    

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Product along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the region-wise market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Active Implantable Medical Devices  Market By Region, From 2019-2024 ( USD Billion )
  2. Global Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  3. Global Implantable Cardioverter Defibrillators Market By Region, From 2019-2024 ( USD Billion )
  4. Global Cardiac Pacemaker Market By Region, From 2019-2024 ( USD Billion )
  5. Global Ventricular Assist Device Market By Region, From 2019-2024 ( USD Billion )
  6. Global Neurostimulator Market By Region, From 2019-2024 ( USD Billion )
  7. Global Implantable Hearing Devices Market By Region, From 2019-2024 ( USD Billion )
  8. North America Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  9. North America Implantable Cardioverter Defibrillators Market By Region, From 2019-2024 ( USD Billion )
  10. North America Cardiac Pacemaker Market By Region, From 2019-2024 ( USD Billion )
  11. North America Ventricular Assist Device Market By Region, From 2019-2024 ( USD Billion )
  12. North America Neurostimulator Market By Region, From 2019-2024 ( USD Billion )
  13. North America Implantable Hearing Devices Market By Region, From 2019-2024 ( USD Billion )
  14. United States Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  15. Canada Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  16. Europe Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  17. Europe Implantable Cardioverter Defibrillators Market By Region, From 2019-2024 ( USD Billion )
  18. Europe Cardiac Pacemaker Market By Region, From 2019-2024 ( USD Billion )
  19. Europe Ventricular Assist Device Market By Region, From 2019-2024 ( USD Billion )
  20. Europe Neurostimulator Market By Region, From 2019-2024 ( USD Billion )
  21. Europe Implantable Hearing Devices Market By Region, From 2019-2024 ( USD Billion )
  22. U.K. Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  23. Germany Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  24. France Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  25. Italy Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  26. Spain Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  27. Asia-Pacific Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  28. Asia-Pacific Implantable Cardioverter Defibrillators Market By Region, From 2019-2024 ( USD Billion )
  29. Asia-Pacific Cardiac Pacemaker Market By Region, From 2019-2024 ( USD Billion )
  30. Asia-Pacific Ventricular Assist Device Market By Region, From 2019-2024 ( USD Billion )
  31. Asia-Pacific Neurostimulator Market By Region, From 2019-2024 ( USD Billion )
  32. Asia-Pacific Implantable Hearing Devices Market By Region, From 2019-2024 ( USD Billion )
  33. Japan Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  34. China Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  35. India Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  36. Australia Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  37. South Korea Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  38. Latin America Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  39. Latin America Implantable Cardioverter Defibrillators Market By Region, From 2019-2024 ( USD Billion )
  40. Latin America Cardiac Pacemaker Market By Region, From 2019-2024 ( USD Billion )
  41. Latin America Ventricular Assist Device Market By Region, From 2019-2024 ( USD Billion )
  42. Latin America Neurostimulator Market By Region, From 2019-2024 ( USD Billion )
  43. Latin America Implantable Hearing Devices Market By Region, From 2019-2024 ( USD Billion )
  44. Brazil Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  45. Argentina Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  46. Mexico Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  47. Rest of Latin America Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  48. Middle East & Africa Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  49. Middle East & Africa Implantable Cardioverter Defibrillators Market By Region, From 2019-2024 ( USD Billion )
  50. Middle East & Africa Cardiac Pacemaker Market By Region, From 2019-2024 ( USD Billion )
  51. Middle East & Africa Ventricular Assist Device Market By Region, From 2019-2024 ( USD Billion )
  52. Middle East & Africa Neurostimulator Market By Region, From 2019-2024 ( USD Billion )
  53. Middle East & Africa Implantable Hearing Devices Market By Region, From 2019-2024 ( USD Billion )
  54. Middle East Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  55. Africa Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample